Kenalog-40 Interactions
There are 617 drugs known to interact with Kenalog-40 (triamcinolone), along with 23 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 107 are major, 475 are moderate, and 35 are minor.
- View all 617 medications that may interact with Kenalog-40
- View Kenalog-40 alcohol/food interactions (2)
- View Kenalog-40 disease interactions (23)
Most frequently checked interactions
View interaction reports for Kenalog-40 (triamcinolone) and the medicines listed below.
- albuterol
- amlodipine
- aspirin
- atorvastatin
- baclofen
- Benadryl (diphenhydramine)
- cetirizine
- cyclobenzaprine
- doxycycline
- Flexeril (cyclobenzaprine)
- furosemide
- gabapentin
- ibuprofen
- levothyroxine
- lisinopril
- losartan
- Lyrica (pregabalin)
- melatonin
- meloxicam
- metformin
- naproxen
- omeprazole
- pantoprazole
- prednisone
- tramadol
- trazodone
- Tylenol (acetaminophen)
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
Kenalog-40 alcohol/food interactions
There are 2 alcohol/food interactions with Kenalog-40 (triamcinolone).
Kenalog-40 disease interactions
There are 23 disease interactions with Kenalog-40 (triamcinolone) which include:
- infections
- prematurity
- (+) tuberculin test
- cirrhosis
- depression/psychoses
- diabetes
- electrolyte imbalance
- fluid retention
- GI perforation
- hyperadrenocorticalism
- hyperlipidemia
- hypothyroidism
- liver disease
- MI
- myasthenia gravis
- myopathy
- ocular herpes simplex
- ocular toxicities
- osteoporosis
- PUD
- scleroderma
- strongyloidiasis
- thromboembolism
Report options
More about Kenalog-40 (triamcinolone)
- Kenalog-40 consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (116)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- Drug class: glucocorticoids
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Nplate
Nplate is used to prevent bleeding episodes in people with chronic immune thrombocytopenic purpura ...
Otezla
Otezla (apremilast) is used to treat plaque psoriasis, psoriatic arthritis, and oral ulcers ...
Benlysta
Benlysta infusion is used to treat active systemic lupus erythematosus (SLE) and active lupus ...
Skyrizi
Skyrizi (risankizumab) is used to treat plaque psoriasis, psoriatic arthritis, ulcerative colitis ...
Stelara
Stelara (ustekinumab) is used to treat Crohn's disease, ulcerative colitis, plaque psoriasis, and ...
Taltz
Taltz (ixekizumab) is used to treat plaque psoriasis, psoriatic arthritis, and ankylosing ...
Xolair
Xolair injection (omalizumab) is used to help improve allergic asthma, nasal polyps, and chronic ...
Jardiance
Jardiance (empagliflozin) is used to treat type 2 diabetes, chronic kidney disease and reduce the ...
Dexamethasone ophthalmic
Dexamethasone ophthalmic is used for conjunctivitis, conjunctivitis, allergic, cyclitis, diabetic ...
Methotrexate
Methotrexate is used to treat certain types of cancer of the breast, skin, head and neck, or lung ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
